Bill Gates Has Nearly 30% of His $35 Billion Portfolio in 1 Stock and It's Not Microsoft

The Gates Foundation holds about $35B in publicly traded stocks, with Berkshire Hathaway making up ~28% (~$9.8B) and Microsoft representing ~10.5% of that stock portfolio. The trust manages $86B in total assets, holds 23 equity positions concentrated with 96% in the top 10, and Berkshire’s size largely reflects ~$43.3B of Berkshire stock donations from Warren Buffett (2006–2024). The foundation sold 2.36M Berkshire B shares in Q4 2025, raising >$1B, and Berkshire and Microsoft are the only portfolio positions routinely sold to fund charitable giving.

Analysis

Large, mission-driven donations of single-stock create a recurring, price-insensitive supply vector that markets underprice as a volatility source. That supply is concentrated in a handful of highly liquid tickers, producing predictable intraday/quarterly liquidity troughs that can widen bid-ask spreads and create short-term dislocations of 3–8% around known selling windows.

Because the recipients monetise to fund spending rather than to optimise market timing, these sales behave like a vanilla negative-flow option on the recipient stock: low informational content but high mechanical impact when size meets thin tape. Counterparties that can take short-term inventory (prop desks, market-makers, options sellers) will extract most of the episodic premium, while long-only funds are left to absorb basis risk.

Second-order winners include non-distributed compounders in the same portfolio that aren’t monetised (lower turnover, less headline selling), which should trade with lower implied vols and tighter effective yields than the headline donors’ tickers. Conversely, securities that compete for benchmark or quant capacity with the donated names can see transient rebalancing headwinds as index flows chase the mechanically created price moves.

Key tail risks: a change in donation mechanics (cash instead of stock) quickly removes the flow and compresses realised volatility within 1–3 quarters; an acceleration of spending or emergency liquidity needs could magnify selling and extend drawdowns beyond 15–20% in stressed market environments. Watch quarterly filings and foundation spending guidance as the highest-signal catalysts for near-term moves.

Key Decisions for Investors

• BRK.B – tactical volatility play: Enter a short-dated put spread 30–45 days before quarter-ends (buy 2–4% OTM puts, sell 12–15% OTM puts) to monetise elevated realised vol from predictable donation-driven selling. Position size = 1–2% NAV; max loss = spread width; target premium capture = 40–80% of risk within the 30–60 day window.
• CNI / WM – defensive core buys: Accumulate CNI and WM on >8–10% intraday dips as 12–24 month holds. Target 20–35% upside with a 10% hard stop; rationale is lower turnover, steady FCF and insulation from donation-driven selling that pressures the headline liquid names.
• NVDA – directional growth exposure: Buy 9–12 month call spreads (delta ~0.35 purchase; sell higher strike to finance premium) to express secular AI upside while capping cost. Allocate 1–2% NAV; max loss = premium; upside target 2–4x premium if AI catalyst set persists over 6–12 months.
• BRK.B – tail hedge (portfolio insurance): Purchase 6–9 month 5–8% OTM puts as insurance for concentrated long exposures to the donor-driven names. Keep hedge size small (0.5–1% NAV) to limit drag; this protects against a sudden acceleration of monetisation that could produce >15% drawdowns.